STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · Real-Time Price · USD
1.890
-0.190 (-9.13%)
At close: Oct 17, 2025, 4:00 PM EDT
1.900
+0.010 (0.53%)
After-hours: Oct 17, 2025, 7:48 PM EDT
STRATA Skin Sciences Revenue
STRATA Skin Sciences had revenue of $7.66M in the quarter ending June 30, 2025, a decrease of -9.15%. This brings the company's revenue in the last twelve months to $32.85M, up 0.36% year-over-year. In the year 2024, STRATA Skin Sciences had annual revenue of $33.56M with 0.61% growth.
Revenue (ttm)
$32.85M
Revenue Growth
+0.36%
P/S Ratio
0.24
Revenue / Employee
$309,887
Employees
106
Market Cap
9.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.56M | 204.00K | 0.61% |
| Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
| Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
| Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
| Dec 31, 2020 | 23.09M | -8.50M | -26.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SSKN News
- 5 days ago - Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides - GlobeNewsWire
- 16 days ago - Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis - GlobeNewsWire
- 19 days ago - STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis - GlobeNewsWire
- 27 days ago - New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach - GlobeNewsWire
- 6 weeks ago - STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering - GlobeNewsWire
- 6 weeks ago - STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients - GlobeNewsWire